Annual Report

Overview

The report presents fiscal 2016 performance for the Kyorin Group, including consolidated net sales of ¥115,373 million and transformation under HOPE100-Stage 2-. It describes CSR priorities covering compliance and risk management, human resources, environmental management and social contribution. Environmental disclosures report 18,192 tons of CO2 emissions for KYORIN Pharmaceutical, and the safety section states that the subsidiary has had no work-related fatality since founding.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2016
Period: 1 April 2016 – 31 March 2017
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services